Health
Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday – Lancet – Reuters UK
Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
LONDON (Reuters) – Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
The vaccine candidate is already in large-scale Phase III human trials to assess whether it can protect against COVID-19, but its developers have yet to report Phase I results which would show whether it is safe and whether or not it induces an immune response.
“We expect this paper, which is undergoing f…
-
General16 hours agoInjured former Greens candidate Hannah Thomas charged with hindering or resisting police at pro-Palestinian protest
-
General15 hours agoTony Burke’s detention inaction | The Spectator Australia
-
General14 hours agoGrattan Institute pitches blueprint to ‘save’ NDIS as foundational supports rollout stalls
-
General11 hours agoAustralian workers lose more than $4.7 billion a year in unpaid super — and the ATO rarely penalises employers